A prospective observational pilot study into the renal effects of using dexmedetomidine for sedation in intensive care

Not Applicable

Completed

• Conditions: Sedation; Renal and Urogenital - Other renal and urogenital disorders

• Registration Number: ACTRN12619000530123
• Lead Sponsor: The Royal Melbourne Hospital IC

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-01-01
• Study Start: 2019-04-03
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Patients will be eligible for participation if their treating doctor was already intending to start them on this treatment (dexmedetomidine) for an existing clinical indication.

Exclusion Criteria

Patients will be excluded if aged less than 18 years, pregnant, or they have acute or chronic end stage kidney failure and are receiving renal replacement therapy.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The effect of dexmedetomidine on urinary pO2[The first 24 hours from the patient starting to receive dexmedetomidine]